Concepedia

Publication | Open Access

m6A-dependent glycolysis enhances colorectal cancer progression

440

Citations

43

References

2020

Year

Abstract

METTL3 is a functional and clinical oncogene in CRC. METTL3 stabilizes HK2 and SLC2A1 (GLUT1) expression in CRC through an m<sup>6</sup>A-IGF2BP2/3- dependent mechanism. Targeting METTL3 and its pathway offer alternative rational therapeutic targets in CRC patients with high glucose metabolism.

References

YearCitations

Page 1